We then examined several additional features that could plausibly be influenced by PD-1 blockade or have been implicated in prior studies, including tumor cell cycle activity, transcriptional programs associated with malignant cell states, interferon-related signaling in both tumor cells and TAMs, and myeloid cell programs. Here, PDCD1 is linked to neoplasm.